Grey Matter Atrophy in Patients Suffering from Multiple Sclerosis
White matter lesions are defining characteristics of multiple sclerosis (MS), whereas grey matter involvement is a less recognised attribute. Recent investigations using dedicated imaging approaches have made it possible to depict cortical lesions. Additionally, grey matter atrophy may be estimated...
Elmentve itt :
Szerzők: | |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2014
|
Sorozat: | IDEGGYOGYASZATI SZEMLE / CLINICAL NEUROSCIENCE
67 No. 9-10 |
Tárgyszavak: | |
mtmt: | 2775214 |
Online Access: | http://publicatio.bibl.u-szeged.hu/22625 |
Tartalmi kivonat: | White matter lesions are defining characteristics of multiple sclerosis (MS), whereas grey matter involvement is a less recognised attribute. Recent investigations using dedicated imaging approaches have made it possible to depict cortical lesions. Additionally, grey matter atrophy may be estimated using various methods. Several studies have suggested that grey matter atrophy closely correlates to clinical disability. In this review we have collected information on grey matter atrophy in MS and the effect of disease modifying therapies upon brain atrophy. |
---|---|
Terjedelem/Fizikai jellemzők: | 293-300 |
ISSN: | 0019-1442 |